These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29958730)

  • 1. Molecular dissection of large cell carcinomas of the lung with null immunophenotype.
    Harms A; Endris V; Winter H; Kriegsmann M; Stenzinger A; Schirmacher P; Warth A; Kazdal D
    Pathology; 2018 Aug; 50(5):530-535. PubMed ID: 29958730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria.
    Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT
    Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
    Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
    J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma.
    Hwang DH; Szeto DP; Perry AS; Bruce JL; Sholl LM
    Arch Pathol Lab Med; 2014 May; 138(5):626-35. PubMed ID: 23738762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma].
    Hou LK; Zhang LP; Zhang W; Huang Y; Wu W; Dong ZW; Wu CY
    Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):298-302. PubMed ID: 28468033
    [No Abstract]   [Full Text] [Related]  

  • 6. Large-cell carcinoma of the lung: a diagnostic category redefined by immunohistochemistry and genomics.
    Sholl LM
    Curr Opin Pulm Med; 2014 Jul; 20(4):324-31. PubMed ID: 24811836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.
    Russell PA; Rogers TM; Solomon B; Alam N; Barnett SA; Rathi V; Williams RA; Wright GM; Conron M
    Pathology; 2017 Oct; 49(6):604-610. PubMed ID: 28811082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Large-cell lung carcinoma by the 2015 WHO classification: a clinicopathologic analysis of 93 cases].
    Zhang JY; Xu XY; Shen Q; Wang YF; Wang X; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):231-6. PubMed ID: 27033385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological analysis of Large Cell Lung Carcinomas definitely diagnosed according to the New World Health Organization Criteria.
    Bi Y; Qu Y; Liang Z; Liu Z; Zhang H; Liang X; Luo Y; Cao J; Zhang H; Feng R
    Pathol Res Pract; 2018 Apr; 214(4):555-559. PubMed ID: 29525405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis, prognosis, and prediction of non-small cell lung cancer. Importance of morphology, immunohistochemistry and molecular pathology].
    Warth A
    Pathologe; 2015 Nov; 36 Suppl 2():194-200. PubMed ID: 26391251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Napsin A/p40 antibody cocktail for subtyping non-small cell lung carcinoma on cytology and small biopsy specimens.
    Nishino M; Hoang MP; Della Pelle P; Morales-Oyarvide V; Huynh TG; Mark EJ; Mino-Kenudson M
    Cancer Cytopathol; 2016 Jul; 124(7):472-84. PubMed ID: 27412420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Large cell carcinoma, lymphoepithelioma-like carcinoma, NUT carcinoma].
    Copin MC
    Ann Pathol; 2016 Jan; 36(1):24-33. PubMed ID: 26739900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
    Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
    J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of two transcriptomic subtypes of marker-null large cell carcinoma of the lung suggests different origin and potential new therapeutic perspectives.
    Simbolo M; Centonze G; Gkountakos A; Monti V; Maisonneuve P; Golovco S; Sabella G; Del Gobbo A; Gobbo S; Ferrero S; Fabbri A; Pardo C; Garzone G; Prinzi N; Pusceddu S; Testi A; Rolli L; Mangogna A; Bercich L; Benvenuti MR; Bria E; Pilotto S; Berruti A; Pastorino U; Capella C; Infante M; Milella M; Scarpa A; Milione M
    Virchows Arch; 2024 May; 484(5):777-788. PubMed ID: 38168015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant.
    Cheung AH; Wong KY; Chau SL; Xie F; Mui Z; Li GY; Li MSC; Tong J; Ng CS; Mok TS; Kang W; To KF
    Pathology; 2024 Jun; 56(4):504-515. PubMed ID: 38413251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Large cell carcinoma of the lung with null immunophenotype: Case report & brief review].
    García Muñiz JA; Romo Garibay R; Vilches Cisneros N; Flores Gutiérrez JP
    Rev Esp Patol; 2023; 56(3):206-211. PubMed ID: 37419561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large cell carcinoma of the lung: a tumor in search of an author. A clinically oriented critical reappraisal.
    Pelosi G; Barbareschi M; Cavazza A; Graziano P; Rossi G; Papotti M
    Lung Cancer; 2015 Mar; 87(3):226-31. PubMed ID: 25620799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic profiling of lung adenocarcinoma patients reveals therapeutic targets and confers clinical benefit when standard molecular testing is negative.
    Lim SM; Kim EY; Kim HR; Ali SM; Greenbowe JR; Shim HS; Chang H; Lim S; Paik S; Cho BC
    Oncotarget; 2016 Apr; 7(17):24172-8. PubMed ID: 26992220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational and gene fusion analyses of primary large cell and large cell neuroendocrine lung cancer.
    Karlsson A; Brunnström H; Lindquist KE; Jirström K; Jönsson M; Rosengren F; Reuterswärd C; Cirenajwis H; Borg Å; Jönsson P; Planck M; Jönsson G; Staaf J
    Oncotarget; 2015 Sep; 6(26):22028-37. PubMed ID: 26124082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.